Delivery Order SPE2DB22D2007-SPE2DB24FH6MH
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $7,942.60 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the pharmaceutical product CREON DR. The contract has an ultimate completion date of February 21, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a delivery order with a firm fixed price valued at $10,355.11. The award is for the supply of 36,000 unit capsules of the pharmaceutical product Creon DR to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,225.46, is a Firm Fixed Price Delivery Order for the provision of 36,000 unit capsules of the drug CREON DR. The contract has an ultimate completion date of October 27, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,336.08 firm fixed-price delivery order covers the supply of 12,000 unit capsules of the pharmaceutical product CREON DR 100S. The contract has an ultimate completion date of April 18, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which specializes in pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,265.02, is a Firm Fixed Price Delivery Order for the supply of 36,000 unit capsules of the pharmaceutical product "CREON DR". The contract has an ultimate completion date of March 24, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,961.70 firm fixed price delivery order is for the supply of 24,000 unit capsules of the medication Creon DR. The contract has an ultimate completion date of October 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,663.54 Firm Fixed Price Delivery Order contract is to supply 36,000 unit capsules of the drug CREON DR. The contract has a completion date of September 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,340.54 firm fixed-price delivery order is for the procurement of 12,000 units of Creon DR 100-count capsules, with an ultimate completion date of October 18, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,801.09 firm fixed-price delivery order is for the supply of 36,000 unit capsules of the pharmaceutical product CREON DR. The contract has an ultimate completion date of October 22, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,533.42 firm fixed-price delivery order contract is for the provision of 24,000 unit capsules of the drug product Creon DR 100s. The contract has a completion date of March 12, 2024 and does not utilize any set-aside designations. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB24FH6MHDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,684.58, is a delivery order for the supply of 36,000 unit capsules of the drug Creon DR 100S. The contract has an ultimate completion date of October 24, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is not designated as a set-aside contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.7k | 10/23/23 |